BCL2 overexpression mitigated the effects of MCL1 inhibition (Fig. 3f, g), indicating the importance of MYC-induced BCL2 repression in defining MCL1 dependency and MYC-specific vulnerabilities in SCLC. The gene discussed is BCL2; the disease is small cell lung carcinoma.